Northwestern Mutual Wealth Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-900	Closed	-$4.31K	–	3960
2024 Q4	$4.31K	Buy	+900	New	+$4.32K	﹤0.01%	2988
2022 Q1	–	Sell	-250	Closed	-$4K	–	3424
2021 Q4	$4K	Buy	+250	New	+$4.36K	﹤0.01%	2860
2020 Q3	–	Sell	-200	Closed	-$2K	–	2691
2020 Q2	$2K	Hold	200	–	–	﹤0.01%	2242
2020 Q1	$2K	Buy	+200	New	+$2.48K	﹤0.01%	2294
2019 Q3	–	Sell	-149	Closed	-$2K	–	2697
2019 Q2	$2K	Buy	+149	New	+$2.37K	﹤0.01%	2356
2016 Q3	–	Sell	-650	Closed	-$7K	–	1484
2016 Q2	$7K	Hold	650	–	–	﹤0.01%	1498
2016 Q1	$5K	Hold	650	–	–	﹤0.01%	1657
2015 Q4	$6K	Hold	650	–	–	﹤0.01%	1283
2015 Q3	$7K	Hold	650	–	–	﹤0.01%	1176
2015 Q2	$8K	Hold	650	–	–	﹤0.01%	1048
2015 Q1	$6K	Hold	650	–	–	﹤0.01%	1159
2014 Q4	$9K	Hold	650	–	–	﹤0.01%	1113
2014 Q3	$7K	Hold	650	–	–	﹤0.01%	985
2014 Q2	$11K	Hold	650	–	–	﹤0.01%	886
2014 Q1	$11K	Buy	+650	New	+$9.24K	﹤0.01%	859

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northwestern Mutual Wealth Management's VNDA Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2025, closing a stake of 900 shares — an estimated $4.31K sold.

Northwestern Mutual Wealth Management first reported a position in VNDA in Q1 2014 and held it in 15 quarters. The position peaked at $11K in Q2 2014. 146 funds tracked by Wall St. Rank hold VNDA as of Q1 2025.

Northwestern Mutual Wealth Management reported no remaining Vanda Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 900 Vanda Pharmaceuticals shares in Q1 2025, an estimated $4.31K.
Northwestern Mutual Wealth Management first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 15 quarters.
Northwestern Mutual Wealth Management's Vanda Pharmaceuticals position peaked at $11K in Q2 2014.
146 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.